We use special terms for our teams: MOGs and SPOREs.

Researchers and treatment specialists meet regularly in multidisciplinary oncology groups, or MOGs for short. Holden’s many resources come together in certain focused areas, known as specialized programs of research excellence, or SPOREs.

Each type of cancer has a MOG at Holden. Your case of breast cancer, for example, would be studied by a full team of care givers and researchers who all specialize in breast cancer. They review your case from your care team’s findings and weigh all possible treatment options. Based on their collective expertise, they map out the best course of treatment for you, which may include participation in clinical trials to take advantage of new and promising treatments.

Holden’s MOGs

  • Breast Cancer
  • Endocrine Cancer
  • Gastrointestinal Cancer
  • Genitourinary Cancer
  • Gynecologic Cancer
  • Head and Neck Cancer
  • Leukemia
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Neuroendocrine Cancer
  • Neurological Cancer
  • Pediatric Cancer
  • Sarcoma
  • Thoracic Cancer

MOGs that have become SPOREs

Among the 15 MOGs actively at work at Holden, two have received special recognition and funding support from the National Cancer Institute (NCI). The NCI identifies programs that have shown outstanding results and have awarded them as specialized programs of research excellence, or SPOREs.

Holden’s two SPOREs, considered among the nation’s best of the best, conduct research and offer treatments for

  • Lymphoma – several types of blood cancers that develop in the lymphatic system
  • Neuroendocrine tumors – cancers that develop in hormone-producing cells in several of the body’s organs